We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+15.72%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$176M
AUM Growth
+$48.5M
Cap. Flow
+$46.6M
Cap. Flow %
26.5%
Top 10 Hldgs %
75.9%
Holding
48
New
17
Increased
4
Reduced
8
Closed
18

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.6M
2
UTHR icon
United Therapeutics
UTHR
+$5.29M
3
ADUS icon
Addus HomeCare
ADUS
+$4.23M
4
ABBV icon
AbbVie
ABBV
+$3.32M
5
UNH icon
UnitedHealth
UNH
+$2.94M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$11.8M
2
GSK icon
GSK
GSK
+$8.99M
3
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$8.74M
4
AFAM
Almost Family Inc
AFAM
+$5.67M
5
CFN
CAREFUSION CORPORATION
CFN
+$5.32M

Sector Composition

Rank Sector Weight
1 Healthcare 45.76%
2 Financials 1.27%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGTX icon
26
TG Therapeutics
TGTX
$8.19B
$1.19M 0.68%
76,924
-25,776
-25% -$390K
ELDN icon
27
Eledon Pharmaceuticals
ELDN
$263M
$930K 0.53%
+508
New +$1.12M
NSPR icon
28
InspireMD
NSPR
$31.5M
– –
0
– –
MMSI icon
29
Merit Medical Systems
MMSI
$4.97B
$467K 0.27%
24,235
-68,837
-74% -$1.23M
BDSI
30
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$201K 0.11%
+169,200
New +$2.31M
ADMA icon
31
ADMA Biologics
ADMA
$2.01B
– –
-245,930
Closed -$2.75M
AKTX
32
Akari Therapeutics
AKTX
$14M
– –
-23
Closed -$881K
CNMD icon
33
CONMED
CNMD
$1.41B
– –
-50,100
Closed -$2.25M
ESPR
34
DELISTED
Esperion Therapeutics
ESPR
– –
-53,600
Closed -$2.17M
GSK icon
35
GSK
GSK
$104B
– –
-168,297
Closed -$8.99M
OFIX icon
36
Orthofix Medical
OFIX
$477M
– –
-78,007
Closed -$2.35M
OPCH icon
37
Option Care Health
OPCH
$3.36B
– –
-138,655
Closed -$3.88M
SNY icon
38
Sanofi
SNY
$103B
– –
-259,500
Closed -$11.8M
LFWD icon
39
ReWalk Robotics
LFWD
$19.7M
– –
-28
Closed -$1.13M
CBAY
40
DELISTED
Cymabay Therapeutics
CBAY
– –
-121,900
Closed -$1.2M
SRNE
41
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-184,720
Closed -$1.86M
ADXS
42
DELISTED
Advaxis Inc
ADXS
– –
-2,600
Closed -$161K
NSPH
43
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-269,311
Closed -$2.11M
CFN
44
DELISTED
CAREFUSION CORPORATION
CFN
– –
-89,600
Closed -$5.32M
CTIC
45
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-50,500
Closed -$1.19M
COV
46
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-85,500
Closed -$8.74M
BDSI
47
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-372,043
Closed -$5.08M
AFAM
48
DELISTED
Almost Family Inc
AFAM
– –
-195,807
Closed -$5.67M
1
2

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Sio Capital Management held 48 positions worth $176M, up 38% from $127M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Sio Capital Management deployed $46.6M of net new capital in Q1 2015, opening 17 new positions and adding to 4 existing holdings. Its largest new stake was Merck: 151,960 shares worth $8.34M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 82% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Agile Therapeutics, an estimated $4.78M trimmed.

  • Sio Capital Management's largest Q1 2015 buy was Merck: 151,960 shares worth $8.34M.
  • Sio Capital Management added most to Biostage, Inc. Common Stock in Q1 2015, an estimated $1.09M increase.
  • Sio Capital Management's biggest Q1 2015 reduction was Agile Therapeutics, cutting an estimated $4.78M.
  • Sio Capital Management fully exited Sanofi in Q1 2015, selling an estimated $11.8M.
  • Sio Capital Management's ten largest holdings make up 76% of its $176M portfolio in Q1 2015.
  • Sio Capital Management opened 17 new positions and closed 18 in Q1 2015.
  • Sio Capital Management's portfolio value rose 38% quarter-over-quarter to $176M.

Based on Sio Capital Management's 13F filing for Q1 2015, filed 15 May 2015.